COVID-19 demonstrates the value of open access: What happens next?
Abstract
In the wake of COVID-19, many publishers have tacitly agreed that open access is beneficial to scientific advancement and necessary to move science forward to combat disease. Publishers have committed to open access publication of scientific articles relating to the disease. Some are facilitating rapid and open peer review and fast-tracking the publishing of related research. Pulitzer Prize-winning journalist Michael Hiltzig refers to this convincing demonstration of the value of open access to scientific research as one of the most important positive disruptions caused by COVID-19.
Copyright Willa Tavernier
Article Views (Last 12 Months)
No data available
Contact ACRL for article usage statistics from 2010-April 2017.
Article Views (By Year/Month)
| 2023 |
| January: 30 |
| February: 11 |
| 2022 |
| January: 112 |
| February: 104 |
| March: 122 |
| April: 69 |
| May: 98 |
| June: 35 |
| July: 54 |
| August: 77 |
| September: 57 |
| October: 137 |
| November: 38 |
| December: 37 |
| 2021 |
| January: 119 |
| February: 93 |
| March: 100 |
| April: 111 |
| May: 131 |
| June: 105 |
| July: 105 |
| August: 123 |
| September: 133 |
| October: 315 |
| November: 379 |
| December: 221 |
| 2020 |
| January: 0 |
| February: 0 |
| March: 0 |
| April: 13 |
| May: 1154 |
| June: 488 |
| July: 221 |
| August: 123 |
| September: 87 |
| October: 356 |
| November: 184 |
| December: 70 |